Active Recombinant Human LBP

• Cat.No.: LBP-267H
• Product Overview: Recombinant Human LBP (Accession # AAD21962) Ala26-Val481 was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Predicted N Terminal: Ala26
• Form: Lyophilized from a 0.2 µm filtered solution in Tris, NaCl and EDTA with BSA as a carrier protein.
• Bio-activity: Measured by its ability to enhance LPS-stimulated IL-8 secretion by THP-1 human acute monocytic leukemia cells.The ED50 for this effect is typically 0.25 - 2.5 ng/mL.
• Molecular Mass: Recombinant Human LBP has a calculated MW of 51 kDa. In SDS-PAGE migrates as 55 - 60 kDa, reducing conditions.
• Purity: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Reconstitution: Reconstitute at 50 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.

Gene Information

• Gene Name: LBP lipopolysaccharide binding protein [ Homo sapiens ]
• Official Symbol: LBP
• Synonyms: LBP; lipopolysaccharide binding protein; lipopolysaccharide-binding protein; BPI fold containing family D; member 2; BPIFD2; LPS-binding protein; BPI fold containing family D, member 2; MGC22233
• Gene ID: 3929
• mRNA Refseq: NM_004139
• Protein Refseq: NP_004130
• MIM: 151990
• UniProt ID: P18428
• Chromosome Location: 20q11.23